Positive biotech M&A activity in 1 hour boosts case for Biotech ETF SBIO

Following notable uncertainties in recent years, M&A activity appears to be on the mend. Biotech M&A activity saw some positive numbers in the first half of this year, according to a new JP Morgan report. That report cited a projection of about 100 M&A moves this year, among other data-enhancing points for the space. Together, (…)

The post Positive Biotech M&A Activity in 1H Boosts Case for Biotech ETF SBIO appeared first on ETF Trends.